跳至主要内容
临床试验/DRKS00025816
DRKS00025816招募中未知

Evaluation of Smartphone-based Monitoring as a Biomarker of Deep-brain Stimulation Response in Parkinson’s disease - SmartDBS

niversitätsklinikum Düsseldorf0 个研究点目标入组 60 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
30 Years 至 80 Years(—)
性别
All

入选标准

  • Levodopa treatment for at least 3 months prior to the first measurement
  • - Ability to understand the study procedure
  • - Planned THS surgery for the treatment of idiopathic Parkinson's syndrome
  • - Eligible for MRI measurement
  • - Informed consent, signed and dated by the subject or, in the case of motor impairment, by an independent witness

排除标准

  • - Presence of a legally authorized representative
  • - Presence of conditions other than idiopathic Parkinson's disease that may worsen motor or cognitive abilities, such as corticobasal syndrome, multisystem atrophy, dementia, severe arthritis, drug/alcohol abuse, Alzheimer's disease, stroke, or similar conditions
  • - Inability to remain seated in the MEG scanner without involuntary movements producing artifacts
  • - Inability to undergo MRI scanning, e.g., metal implants or tattoos containing metal
  • - Past or present participation in pharmacologic clinical trials related to idiopathic Parkinson's syndrome
  • - Claustrophobia
  • - Unable to tolerate levodopa medication withdrawal for at least 12 hours (including dysphagia, tendency to fall)
  • - Inability to walk

研究者

发起方
niversitätsklinikum Düsseldorf

相似试验

Evaluation of Smartphone-based Monitoring as a... | 临床试验